www.Top100Pharmacy.com - TOP 100 PHARMACY SITES
TOP 100 PHARMACY SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Mon, June 16, 2008.
251.www.knmp.nl11000
252.www.sanofipasteur.com10900
253.www.astrazeneca.fr10900
254.www.bayervital.de10900
255.www.altana.com10900
256.www.ambien.com10800
257.www.pfizer.ch10800
258.www.exelixis.com10700
259.www.biospecifics.com10700
260.www.tylenol.com10600
261.www.bionorica.de10600
262.www.nycomed.ru10500
263.www.astrazeneca.de10500
264.www.menarini.com10300
265.www.ferring.com10200
266.www.clinicalneuropharm.com10000
267.www.pfizer.no9980
268.www.takeda.com9780
269.www.ebdgroup.com9700
270.www.alpharma.com9690
271.www.bavarian-nordic.com9650
272.www.guild.org.au9630
273.www.farmasalute.it9590
274.www.mochida.co.jp9550
275.www.breggin.com9450
276.www.factsandcomparisons.com9430
277.www.farmamondo.com9410
278.www.creapharma.ch9410
279.pharmacy.ouhsc.edu9380
280.www.florahealth.com9360
281.www.mdsps.com9330
282.www.cuttingedgeinfo.com9140
283.www.medsmex.com6680
284.www.feelbest.com6300
285.www.candrugstore.com6110
286.www.nymox.com5920
287.www.treatingyourself.com5810
288.zocor.com5690
289.www.epharma.md5350
290.www.nutropin.com4670
291.www.iberogast.de4340
292.www.glivec.com4310
293.www.paxil.com4030
294.1800patches.com3940
295.www.curis.com3580
296.www.xeloda.com3570
297.us.boehringer-ingelheim.com3520
298.www.nastech.com3470
299.www.uhlmann.de3260
300.www.intermune.com3250
Pages:  1  2  3  4  5  6  7  8  9  10 


Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Furl Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Ma.gnolia Add to Newsvine Add to Shadows

258. www.exelixis.com

Rating: 10700 points*
*amount mentions of word 'www.exelixis.com' on the other websites

www.exelixis.com

Exelixis-an integrated drug discovery and development company, drug research, discovery and clinical development

Description: Exelixis is an integrated drug discovery and development company. Our primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease.

Most popular searches: www.exelixis, www.exelxis.com, www.exelixi.com, ww.exelixis.com, www.exelixis.cmo, www.exelxiis.com, www.exeliixs.com, www.xelixis.com, www.eelixis.com, www.exeliis.com, www.eexlixis.com, wwwexelixis.com, www.exelixis.ocm, www.exeixis.com, www.exelixis.cm, wwwexelixis.com, ww.exelixis.com, bioinformatics, www.exelixis.om, www.exelixs.com, www.exelixis.co, ww.wexelixis.com, wwwe.xelixis.com, www.exeilxis.com, www.xeelixis.com, www.exleixis.com, www.exelixis.com, www.exelixi.scom, www.exelixiscom, Biotech biotechnology Drug discovery development company invertebrate and vertebrate genetics and comparative genomics, www.exelixisc.om, www.exlixis.com, cell biology and protein production cutting-edge genomic molecular biology combinatorial chemistry technologies develop innovative therapies human diseases therapeutics complex molecular causes of disease, www.exelixsi.com

Google

© 2005-2008 www.Top100Pharmacy.com
Newsweek: Health care goes open-source
Is it a good idea to apply open-source principles to private health matters? Electronic health records are a step in that direction, and some experts go further, arguing that if transparency and openness can work wonders for software, it can also benefit diabetics and Parkinson's sufferers.
newsweek.com
NYT: GOP may be bypassed on health care
NYT analysis: Democrats are tempted to use their political muscle to speed passage of health care legislation with minimal concessions to the Republican minority.
msnbc.msn.com
Nigeria meningitis death toll surpasses 2,000
A meningitis outbreak in Nigeria is more serious than initially feared with the death toll rising more than sixfold over the past two months, the Health Ministry said on Wednesday.
msnbc.msn.com
Limiting malpractice lawsuits can save big
Limits on medical malpractice lawsuits would lead doctors to order up fewer unneeded tests and save taxpayers billions more than previously thought.
msnbc.msn.com
F.D.A. Says No, for Now, to an Amgen Bone Drug
The agency declined to approve a medication called denosumab, meant to treat osteoporosis, until it has more data.
nytimes.com